This study focuses on the manipulation of the plexin-B1 protein to enhance the brain’s ability to clear amyloid plaques in Alzheimer’s disease, opening avenues for future therapeutic strategies to potentially halt the progression of the disease
This study focuses on the manipulation of the plexin-B1 protein to enhance the brain’s ability to clear amyloid plaques in Alzheimer’s disease, opening avenues for future therapeutic strategies to potentially halt the progression of the disease
Thanks, that was a good read. It is terrible that some researchers end up committing such scientific fraud. Although I am inclined to blame the involved researchers themselves, ultimately, I believe that inflexible (and insufficient) funding is the real culprit